Treatment for chemotherapy-related arthropathy (CRA) with disease modifying antirheumatic drugs (DMARDs)

Treatment for chemotherapy-related arthropathy (CRA) with disease modifying antirheumatic drugs (DMARDs): results of an open-labelled multicenter pilot study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000160

Enrollment

Registered

2011-08-02

Start date

2007-08-06

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In order to compare the efficacy of HCQ with nonsteroidal anti-inflammatory drugs (NSAIDs) and NSAIDs for the treatment of CRA, an open-labelled clinical trial was carried out at 7 tertiary hos

DMARDs group vs. NSAIDs

NSAIDs group). Because double-blind trial will be difficult, patients will be enrolled to DMARDs group or NSAIDs group in regular sequence. NSAIDs of whatever description could be prescribed, and pati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We enroll patients who, after starting chemotherapy, developed arthritis or arthralgia with their agreement.

Exclusion criteria

Exclusion criteria: We exclude patients who were dianosed by rheumatoid arthritis or lupus, had bone metastasis of cancer, or don't want this clinical trial.

Design outcomes

Primary

Measure	Time frame
Tendor and swollen joint count;Visual analogue pain score and morning stiffness;ESR and CRP	—

Secondary

Measure	Time frame
add on therapy	—

Countries

Korea, Republic of

Contacts

Public ContactHyoun-Ah Kim

Ajou University

Outcome results